CellPharma signs important contract with Liberty and leaves Aduim Pharma in the brink of bankrupt.

McTychson Company, Frankfurt - CellPharma has signed today a multi-millionaire contract with Liberty government to produce and provide FFV virus antidote to all governmental and civilian medical facilities in Liberty. this has been achieved after Adium Pharma, which was previous provider failed to deliver the required amount of supplies due to a strike of Adium Pharma Workers Syndicate (APWS).

The agreement also included that Transcargo will be making the distribution from CellPharma Labs on Earth to Manhattan in Liberty, from where the supplies will be distributed within Liberty by other companies.

Implications for the Parts

With this contract, CellPharma increases its production demand in 350%, which places this labs in the first place of Bio-Engineering Production in all Sirius. This may also lead the company to buy the remaining 75% of Costa Pharma company shares. Currently McTychson Company holds 25% of Costa Pharma, and as CellPharms is part of McTychson Company Economic Investment Group, this would leave the company with the two Greatest bio-engineering production companies in the market.

Adium Pharma has as a consequence of this, lost the greatest source of commercial income, as the contract with Liberty meant 98% of its latest important and stable contract business. Aduim Pharma will now have to struggle to obtain commercial agreements with potential new clients in order to survive.